Boiling histotripsy and in-situ CD40 stimulation improve the checkpoint blockade therapy of poorly immunogenic tumors

Background: Advanced stage cancers with a suppressive tumor microenvironment (TME) are often refractory to immune checkpoint inhibitor (ICI) therapy. Recent studies have shown that focused ultrasound (FUS) TME-modulation can synergize ICI therapy, but enhancing survival outcomes in poorly immunogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Mohit Pratap, Sethuraman, Sri Nandhini, Miller, Craig, Malayer, Jerry, Ranjan, Ashish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738858/
https://www.ncbi.nlm.nih.gov/pubmed/33391491
http://dx.doi.org/10.7150/thno.49517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738858/
https://www.ncbi.nlm.nih.gov/pubmed/33391491
http://dx.doi.org/10.7150/thno.49517

Ejemplares similares